MedPath

A clinical trial to study the effect of Tikta Kshira Basti with and without Virechana followed by Ghrita Pana in patients with Asthimajjagata Vata (Avascular Necrosis of Femoral Head)

Phase 2
Conditions
Health Condition 1: M879- Osteonecrosis, unspecified
Registration Number
CTRI/2019/12/022279
Lead Sponsor
ational Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having classical signs and symptoms of Asthimajjagata Vata

Patient having sign and symptoms of Avascular Necrosis of Femoral Head

Patients fit for Virechana, Basti and Snehapana.

Patients between the age group 18-60 years of either sex

Pre-collapse (Ficat and Arlet stage 1-2) hips

Patients with a Ficat and Arlet Stage 3 or 4 hips who are not willing to go with Surgical intervention will also be included in this study

Exclusion Criteria

Patients having age less than 18 years & above 60 years.

Patients known case of Sickle cell anemia and thalassemia, uncontrolled Hypertension and any serious systemic diseases.

Pregnant and lactating women.

Patients contraindicated for Virechana, Basti and Snehapana.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Harris Hip ScoreTimepoint: After completion of trial
Secondary Outcome Measures
NameTimeMethod
Changes in sign and symptoms of Asthimajjagata Vata (Avascular Necrosis of Femoral Head) <br/ ><br>Changes in Walking Time <br/ ><br>Changes in Quality of Life <br/ ><br>Timepoint: After completion of trial
© Copyright 2025. All Rights Reserved by MedPath